|
Synonyms: ADX-324 | ADX324
Compound class:
Nucleic acid
Comment: Onvuzosiran (ADX-324) is a GalNAc-conjugated small interfering RNA (siRNA) that is proposed to reduce prekallikrein (PKK) expression at the mRNA level. GalNAc conjugation is used to promote targeted hepatic delivery. in the nucleotide sequences provided here (reproduced from the INN record) the GalNAc sugar is attached at the R1 position. The nucleotides are chemically modified (2'-O-methylnucleotides/2'-MOE and 2'-deoxy-2'-fluoronucleotide/2'-F monomers), with a mixed phosphorothioate/phosphate backbone, to improve RNA binding and pharmacokinetics.
|
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | siRNA |
| Target | prekallikrein (PKK) mRNA |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13361 | onvuzosiran |
Synonyms ![]() |
| ADX-324 | ADX324 |
Database Links ![]() |
|
| CAS Registry No. | 2982817-49-0 (source: WHO INN record) |
| Search PubMed clinical trials | onvuzosiran |
| Search PubMed titles | onvuzosiran |
| Search PubMed titles/abstracts | onvuzosiran |